GO:0001791 IgM binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0001791 IgM binding is a molecular function defined as binding to an immunoglobulin of the IgM isotype.
• The best-characterized IgM-binding proteins include the human IgM Fc receptor (FcμR) and pathogen-encoded proteins such as Plasmodium falciparum PfEMP1 and VAR2CSA [1,2,3,5,6].
• FcμR binds IgM through specific amino acid residues in its Ig-like domain, and the FcμR binding site on IgM maps to the Fc region [1,5].
• IgM binding can be modulated by associated proteins such as CD5L, which associates with IgM via the J chain.
• IgM binding by pathogen proteins can inhibit host receptor interactions, as shown for the IgM-VAR2CSA complex blocking Plasmodium falciparum binding to chondroitin sulfate A.
• Studying IgM binding requires combining binding assays, structural biology, and CRISPR-based cell models to dissect receptor-ligand interactions [1,2,3,4,5,6].
Description
GO:0001791 IgM binding is a molecular function term in the Gene Ontology that describes the selective interaction of a protein or molecular complex with an immunoglobulin of the IgM isotype [1,3,5]. IgM is the first antibody class produced during an immune response and forms pentameric or hexameric complexes that are critical for complement activation and pathogen neutralization. Proteins that bind IgM participate in immune surveillance, pathogen immune evasion, and regulation of B cell responses [1,3,5]. Understanding the molecular basis of IgM binding is therefore relevant to immunology, infectious disease, and therapeutic antibody design.
IgM binding At A Glance
| GO ID | GO:0001791 |
|---|---|
| GO term | IgM binding |
| Ontology | molecular_function |
| Synonym | none |
| Definition | Binding to an immunoglobulin of the IgM isotype. |
| Major function | Mediates recognition and interaction with IgM antibodies by receptors or pathogen proteins. |
| Representative proteins | FcμR, PfEMP1, VAR2CSA, CD5L, pIgR-like proteins |
| Related diseases | Malaria, immune dysregulation, allergy-related inflammation |
| Research methods | Surface plasmon resonance, ELISA, cryo-EM, CRISPR knockout |
What Is GO:0001791?
According to the Gene Ontology, GO:0001791 IgM binding is defined as binding to an immunoglobulin of the IgM isotype. This function is mediated by specific protein domains that recognize the constant regions of the IgM heavy chain, often within the Fc portion, and can occur on host immune receptors or pathogen-derived proteins [1,2,3,5,6].
Why Is IgM binding Important in Cell Biology?
IgM binding is important because IgM is a key effector of humoral immunity, and proteins that bind IgM can either promote immune clearance or enable pathogen evasion. The human IgM Fc receptor (FcμR) binds IgM and regulates B cell survival and antibody responses [1,3,5]. Pathogens such as Plasmodium falciparum express IgM-binding proteins that modulate host cell adhesion and immune recognition [2,6]. Additionally, IgM-binding molecules like CD5L influence IgM stability and function. Thus, understanding IgM binding at the molecular level informs vaccine design, immunotherapy, and infectious disease research.
• IgM binding is central to immune recognition of pathogens and altered self-antigens [1,3,5].
• FcμR-mediated IgM binding regulates B cell development and antibody production [1,3,5].
• Plasmodium falciparum IgM-binding proteins contribute to malaria pathogenesis and immune evasion [2,6].
• IgM binding by CD5L modulates IgM effector functions and inflammation.
• Dysregulated IgM binding is associated with autoimmune and allergic conditions.
• IgM-binding proteins are potential targets for therapeutic antibodies and vaccines [2,6].
• Structural studies of IgM-receptor complexes guide rational design of inhibitors [1,2,5].
• CRISPR screens can identify novel genes required for IgM binding and downstream signaling [1,5].
Molecular Mechanism of IgM binding
Recognition of IgM Fc region by FcμR
In simple terms: The receptor grabs the tail end of the IgM antibody.
The human IgM Fc receptor (FcμR) binds the Fc portion of IgM. Mapping studies have identified the binding site for FcμR in human IgM-Fc, and critical amino acid residues in FcμR that mediate this interaction have been defined [1,5]. This binding is essential for FcμR-mediated signaling and B cell regulation [1,3,5].
Pathogen IgM-binding proteins and immune evasion
In simple terms: Some parasites use their own proteins to catch IgM and hide from the immune system.
Plasmodium falciparum expresses PfEMP1 and VAR2CSA proteins that bind IgM. The minimal binding region of a P. falciparum IgM-binding PfEMP1 domain has been identified. Cryo-EM of the IgM-VAR2CSA complex revealed that IgM binding inhibits the interaction of P. falciparum with chondroitin sulfate A, a key step in placental malaria.
Modulation by CD5L and J chain
In simple terms: Other proteins can stick to IgM and change how it binds.
CD5L associates with IgM via the J chain, forming a complex that can alter IgM function. This interaction highlights that IgM binding is not limited to canonical Fc receptors but can involve auxiliary proteins that modify IgM activity.
IgM-binding proteins in mucosal immunity
In simple terms: In fish, a protein similar to the polymeric immunoglobulin receptor binds IgM in the gut.
A pIgR-like molecule expressed by intestinal epithelial cells in common carp binds IgM, indicating that IgM-binding functions are conserved in mucosal immune systems. This suggests that IgM binding plays a role in mucosal defense across vertebrates.
Regulation by proteolysis and inflammation
In simple terms: Inflammation can cut antibodies, affecting how they bind.
Proteolysis of IgE during inflammation has been shown to control allergy, and similar mechanisms may influence IgM binding. This implies that the inflammatory environment can modulate immunoglobulin-receptor interactions, including IgM binding.
Key Genes Involved in GO:0001791 IgM binding
The following genes and proteins are directly implicated in IgM binding or its regulation, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| FCMR | Encodes FcμR, the human IgM Fc receptor | Critical for IgM binding and B cell regulation [1,3,5] |
| IGHM | Encodes the IgM heavy chain constant region | Provides the Fc region bound by FcμR and pathogen proteins [1,2] |
| CD5L | Associates with IgM via J chain | Modulates IgM function and inflammation |
| JCHAIN | Joins IgM monomers via disulfide bonds | Required for CD5L association with IgM |
| VAR2CSA | P. falciparum protein that binds IgM | Mediates placental malaria and immune evasion |
| PFEMP1 | P. falciparum erythrocyte membrane protein 1 | Contains IgM-binding domains |
| PIGR | Polymeric immunoglobulin receptor | Binds IgM in mucosal epithelia |
| FCAMR | Fc alpha/mu receptor | Binds both IgA and IgM |
| CD79A | B cell receptor component | Signals downstream of IgM binding |
| CD79B | B cell receptor component | Signals downstream of IgM binding |
| SYK | Spleen tyrosine kinase | Mediates signaling after IgM binding |
| BTK | Bruton tyrosine kinase | Involved in B cell signaling downstream of IgM |
| C1Q | Complement component | Binds IgM Fc to initiate complement |
| C3 | Complement component | Interacts with IgM-bound complexes |
| FCGR2B | Inhibitory Fc receptor | Modulates B cell responses to IgM |
| IL6 | Inflammatory cytokine | Regulates IgM production and binding |
| TNF | Inflammatory cytokine | Influences IgM-mediated inflammation |
How Is IgM binding Regulated?
IgM binding is regulated at multiple levels. The expression of FcμR on B cells and T cells is tightly controlled during development and activation [1,3,5]. Proteolytic cleavage of immunoglobulins, as shown for IgE in allergy, can alter binding properties and downstream effects. Additionally, the association of CD5L with IgM via the J chain provides a mechanism to modulate IgM binding to receptors and other ligands. Inflammatory cytokines such as IL-6 and TNF can influence IgM production and the availability of binding partners.
IgM binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| FCMR | B cell malignancies, autoimmunity | FCMR knockout B cell lines [1,5] |
| VAR2CSA | Placental malaria | VAR2CSA knock-in P. falciparum |
| PFEMP1 | Malaria immune evasion | PFEMP1 domain knockout parasites |
| CD5L | Inflammation, allergy | CD5L knockout mice |
| JCHAIN | IgM polymerization defects | JCHAIN knockout cell lines |
Malaria and placental infection
Plasmodium falciparum uses IgM-binding proteins such as VAR2CSA and PfEMP1 to adhere to host tissues. The IgM-VAR2CSA complex inhibits binding to chondroitin sulfate A, which may affect placental malaria pathogenesis [2,6]. Targeting these interactions could reduce malaria complications.
B cell malignancies and autoimmunity
FcμR (FCMR) is expressed on B cells and its interaction with IgM regulates B cell survival and activation. Dysregulated FcμR-IgM binding has been implicated in B cell malignancies and autoimmune diseases [1,3,5]. Understanding the structural basis of this interaction may guide therapeutic development [1,5].
Allergy and inflammation
Inflammation-associated proteolysis of IgE controls allergy, and similar mechanisms may affect IgM binding and function. CD5L, which binds IgM via the J chain, is involved in inflammatory responses and could be a therapeutic target.
From IgM binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does FcμR mediate IgM binding in B cells? | FCMR knockout B cell line [1,5] |
| Which residues in FcμR are critical for IgM binding? | Point-mutated FCMR knock-in |
| How does IgM binding affect B cell signaling? | Tagged FCMR knock-in for imaging |
| Can CD5L modulate IgM binding? | CD5L overexpression in IgM-producing cells |
| Does VAR2CSA IgM binding affect malaria adhesion? | VAR2CSA knockout P. falciparum |
| What genes regulate IgM binding? | Genome-wide CRISPR knockout screen [1,5] |
How to Study the IgM binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Surface plasmon resonance | Binding affinity and kinetics | FcμR-IgM interaction [1,5] |
| ELISA | IgM binding specificity | Screening for IgM-binding proteins |
| Cryo-EM | 3D structure of complexes | IgM-VAR2CSA structure |
| CRISPR knockout screen | Genes required for IgM binding | Identifying novel regulators [1,5] |
| Co-immunoprecipitation | Protein-protein interactions | CD5L-IgM association |
| Flow cytometry | Cell surface IgM binding | B cell receptor studies |
| Mutagenesis | Residues critical for binding | FcμR binding site mapping |
Binding assays
Surface plasmon resonance (SPR) and ELISA are used to measure the affinity and kinetics of IgM binding to receptors or pathogen proteins [1,3,5]. These methods can quantify the effects of mutations in FcμR or IgM [1,5].
Structural biology
Cryo-electron microscopy (cryo-EM) and X-ray crystallography provide high-resolution structures of IgM in complex with binding partners, as demonstrated for the IgM-VAR2CSA complex. These structures reveal the binding interface and guide mutagenesis.
CRISPR-based screens
Genome-wide CRISPR knockout screens can identify genes required for IgM binding and downstream signaling. Such screens have been used to dissect FcμR-dependent pathways [1,5].
Proteomics and interactomics
Mass spectrometry-based proteomics can identify proteins that co-precipitate with IgM, such as CD5L, and map interaction networks. This approach is useful for discovering novel IgM-binding proteins.
How CRISPR Can Be Used to Study GO:0001791 IgM binding
Knockout
CRISPR knockout of FCMR or other candidate genes can abolish IgM binding and reveal its functional consequences in B cells or other cell types [1,5]. Knockout of pathogen genes like VAR2CSA can test their role in IgM binding and immune evasion.
Point Mutation
Point mutations in FCMR can be introduced to map residues critical for IgM binding, as identified by alanine scanning and structural studies. Similarly, mutations in IgM Fc can define the receptor-binding site.
Knock-in
Knock-in of tagged FCMR or IgM allows visualization and tracking of IgM binding in live cells. Knock-in of pathogen IgM-binding domains into model organisms can model disease.
Overexpression
Overexpression of CD5L or other IgM-binding proteins can enhance IgM binding and modulate downstream effects, providing gain-of-function models.
How EDITGENE Supports IgM binding Research
Researchers studying IgM binding-related genes often need to determine whether a candidate gene is causally involved in IgM recognition, signaling, or immune evasion. EDITGENE provides comprehensive CRISPR services to generate precisely engineered cell models for such studies.
Contact EDITGENE today to design your custom CRISPR model for IgM binding research.
Frequently Asked Questions About IgM binding
What is GO:0001791 IgM binding?
GO:0001791 IgM binding is a Gene Ontology molecular function term defined as binding to an immunoglobulin of the IgM isotype.
What genes are involved in IgM binding?
Key genes include FCMR (FcμR), IGHM, CD5L, JCHAIN, and pathogen genes like VAR2CSA and PFEMP1 [1,2,4,5,6].
How does FcμR bind IgM?
FcμR binds the Fc region of IgM through specific amino acid residues, as mapped by mutagenesis and structural studies [1,5].
What is the role of IgM binding in malaria?
Plasmodium falciparum proteins such as VAR2CSA and PfEMP1 bind IgM, which can inhibit parasite adhesion to chondroitin sulfate A and modulate immune evasion [2,6].
Can CRISPR be used to study IgM binding?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are powerful tools to dissect IgM binding mechanisms [1,4,5].
What diseases are associated with IgM binding?
IgM binding is linked to B cell malignancies, autoimmunity, malaria, and allergy-related inflammation [1,2,4,5,8].
How is IgM binding measured?
Common methods include surface plasmon resonance, ELISA, cryo-EM, and co-immunoprecipitation [1,2,3,4,5].
What is the binding site for FcμR on IgM?
The binding site for FcμR maps to the Fc region of human IgM, as identified by mapping studies.
Does CD5L affect IgM binding?
CD5L associates with IgM via the J chain and can modulate IgM function.
What model systems are used to study IgM binding?
Cell lines, knockout mice, and pathogen models are commonly used, along with CRISPR-engineered cells [1,2,4,5].
Conclusion
GO:0001791 IgM binding is a fundamental molecular function with broad implications for immunity, infection, and disease. The interaction of IgM with host receptors like FcμR and pathogen proteins like VAR2CSA and PfEMP1 is critical for immune regulation and pathogenesis [1,2,3,5,6]. Advances in structural biology and CRISPR-based models continue to reveal the molecular details of IgM binding, offering new avenues for therapeutic intervention [1,2,4,5].
References
- 1. Nyamboya RA et al.. 2020. Mapping of the binding site for FcμR in human IgM-Fc.. Biochim Biophys Acta Proteins Proteom 1868(1):140266 PMID: 31449905
- 2. Akhouri RR et al.. 2023. Cryo-electron microscopy of IgM-VAR2CSA complex reveals IgM inhibits binding of Plasmodium falciparum to Chondroitin Sulfate A.. Nat Commun 14(1):6391 PMID: 37828011
- 3. Honjo K et al.. 2015. Unique ligand-binding property of the human IgM Fc receptor.. J Immunol 194(4):1975-82 PMID: 25601920
- 4. Wang Y et al.. 2024. CD5L associates with IgM via the J chain.. Nat Commun 15(1):8397 PMID: 39333069
- 5. Skopnik CM et al.. 2020. Identification of Amino Acid Residues in Human IgM Fc Receptor (FcµR) Critical for IgM Binding.. Front Immunol 11:618327 PMID: 33584711
- 6. Semblat JP et al.. 2015. Identification of the minimal binding region of a Plasmodium falciparum IgM binding PfEMP1 domain.. Mol Biochem Parasitol 201(1):76-82 PMID: 26094597
- 7. Zhang F et al.. 2015. Characterization of IgM-binding protein: A pIgR-like molecule expressed by intestinal epithelial cells in the common carp (Cyprinus carpio L.).. Vet Immunol Immunopathol 167(1-2):30-5 PMID: 26166176
- 8. Ugarte-Berzal E et al.. 2025. An Inflammation-Associated Control Mechanism of Allergy by Proteolysis of IgE.. Allergy 80(10):2781-2799 PMID: 40785316
